The U.S. Health Economics and Outcomes Research (HEOR) organization at Celgene is responsible for developing, executing and communicating strategies to help define the real-world value of our hematology and oncology (HemOnc) and Inflammation and Immunology (I&I) products. The real-world evidence generated by HEOR aims to limit barriers to access, optimize utilization, and expand the clinical and economic body of evidence for Celgene products and associated disease states.
The objective of the program is to fully prepare the fellow for a career as a HEOR professional through practical training at Celgene with possible supplemental coursework from Rutgers University towards completion of a related masters degree. The fellow will have the opportunity to understand the role of HEOR throughout the lifecycle of a product and will be involved with various HEOR studies, including comparative effectiveness, real-world evidence generation, health economic modeling, and patient-reported outcomes.
Fellows for the Rutgers Pharmaceutical Industry Fellowship Program are selected on a nationally-competitive basis. Candidates must have completed a Doctor of Pharmacy degree from an ACPE accredited institution before July 1 of the fellowship term.
Participation in the ASHP Midyear Clinical Meeting/PPS is strongly encouraged. Interested individuals are invited to electronically submit a curriculum vitae, three letters of recommendation and a letter of intent and complete a program interest form online by visiting our website at: pharmafellows.rutgers.edu
All application materials must only be submitted electronically via our website, pharmafellows.rutgers.edu (Applicant portal) as early as November 18th. Applicants are strongly encouraged to submit a CV, Letter of Intent and (1) Letter of Recommendatation by December 1st.
Please address your Letter of Intent & Letters of Recommendation to: